Skip to main content
. 2017 Oct 25;106(Suppl 6):1681S–1687S. doi: 10.3945/ajcn.117.156042

TABLE 1.

Anthropometric, hematologic, and biochemical outcomes of iron-supplemented and unsupplemented iron-replete and non–iron-replete infants at the 12-mo follow-up1

Iron replete (n = 154)2
Non–iron replete (n = 452)
Fe (n = 80) Nonsupplemented (n = 74) P3 Fe+ (n = 220) Fe− (n = 232) P4
WAZ5 −1.99 ± 1.02 −1.58 ± 1.13 <0.001 −1.60 ± 1.03 −1.63 ± 1.05 0.45
ΔWAZ5 −1.45 ± 0.46 −1.03 ± 0.63 <0.001 −1.23 ± 0.56 −1.27 ± 0.54 0.44
WLZ5 −1.37 ± 1.17 −0.85 ± 1.27 0.001 −0.87 ± 1.10 −0.89 ± 1.06 0.39
LAZ5 −0.79 ± 1.05 −0.83 ± 0.93 0.83 −0.79 ± 0.84 −0.82 ± 0.92 0.68
Hemoglobin,5 g/L 119.2 ± 15.3 117.6 ± 15.4 0.43 116.7 ± 14.9 113.6 ± 15.8 0.03
SF,6 μg/L 47.5 ± 2.0 20.7 ± 2.2 0.04 36.8 ± 2.6 11.7 ± 3.7 <0.001
Serum zinc,5 μmol/L 9.7 ± 2.5 10.5 ± 3.1 0.04 10.3 ± 3.3 10.9 ± 4.1 0.12
1

Adapted from Lind et al. (13) with permission. Fe−, no Fe provided; Fe+, Fe drops; LAZ, length-for-age z score; SF, serum ferritin; WAZ, weight-for-age z score; WLZ, weight-for-length z score; ΔWAZ, weight-for-age change from baseline to follow-up.

2

Hemoglobin concentration ≥113 g/L and SF concentration ≥33 μg/L at 6 mo of age.

3

ANOVA for difference between Fe+ and Fe− iron-replete infants.

4

ANOVA for difference between Fe+ and Fe− non–iron-replete infants.

5

All values are means ± SDs.

6

All values are antilogs of mean ln values ± SDs.

HHS Vulnerability Disclosure